Identification and characterization of the CDK12/cyclin L1 complex involved in alternative splicing regulation

Molecular and Cellular Biology

Volumn 26, Issue 7, 2006, Pages 2736-2745

  Chen, Hung Hsi ^a   Wang, Yu Chiuan ^a   Fann, Ming Ji ^a,b  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b University System of Taiwan   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE 12; CYCLIN L1; CYCLIN L2; SERINE; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ALTERNATIVE RNA SPLICING; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN FAMILY; PROTEIN INTERACTION; RAT; RNA PROCESSING;

ALTERNATIVE SPLICING; ANIMALS; CLONING, MOLECULAR; CYCLIN-DEPENDENT KINASES; CYCLINS; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENOME; HUMANS; MOLECULAR SEQUENCE DATA; NUCLEAR PROTEINS; PEPTIDE MAPPING; PREGNANCY; PROTEIN BINDING; RATS; RATS, SPRAGUE-DAWLEY; RIBONUCLEOPROTEINS; RNA, MESSENGER; SEQUENCE ANALYSIS, DNA;

ANIMALIA;

EID: 33645214031     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.26.7.2736-2745.2006     Document Type: Article

References (33)

1. Berke, J. D., V. Sgambato, P. P. Zhu, B. Lavoie, M. Vincent, M. Krause, and S. E. Hyman. 2001. Dopamine and glutamate induce distinct striatal splice forms of Ania-6, an RNA polymerase II-associated cyclin. Neuron 32:277-287.
2. Black, D. L. 2000. Protein diversity from alternative splicing: a challenge for bioinformatics and post-genome biology. Cell 103:367-370.
3. Brett, D., J. Hanke, G. Lehmann, S. Haase, S. Delbruck, S. Krueger, J. Reich, and P. Bork. 2000. EST comparison indicates 38% of human mRNAs contain possible alternative splice forms. FEBS Lett. 474:83-86.
4. Caceres, J. F., T. Misteli, G. R. Screaton, D. L. Spector, and A. R. Krainer. 1991. Role of the modular domains of SR proteins in subnuclear localization and alternative splicing specificity. J. Cell Biol. 138:225-238.
5. Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156-159.
6. de Graaf, K., P. Hekerman, O. Spelten, A. Herrmann, L. C. Packman, K. Bussow, G. Muller-Newen, and W. Becker. 2004. Characterization of cyclin L2, a novel cyclin with an arginine/serine-rich domain: phosphorylation by DYRK1A and colocalization with splicing factors. J. Biol. Chem. 279:4612-4624.
7. Dickinson, L. A., A. J. Edgar, J. Ehley, and J. M. Gottesfeld. 2002. Cyclin L is an RS domain protein involved in pre-mRNA splicing. J. Biol. Chem. 277:25465-25473.
8. Edwards, M. K., and M. W. McBurney. 1983. The concentration of retinoic acid determines the differentiated cell types formed by a teratocarcinoma cell line. Dev. Biol. 98:187-191.
9. Fu, X. D. 1995. The superfamily of arginine/serine-rich splicing factors. RNA 1:663-680.
10. Garcia-Blanco, M. A., A. P. Baraniak, and E. L. Lasda. 2004. Alternative splicing in disease and therapy. Nat. Biotechnol. 22:535-546.
11. Hartmann, A. M., O. Nayler, F. W. Schwaiger, A. Obermeier, and S. Stamm. 1999. The interaction and colocalization of Sam68 with the splicing-associated factor YT521-B in nuclear dots is regulated by the Src family kinase p59(fyn). Mol. Biol. Cell 10:3909-3926.
12. Hu, D., A. Mayeda, J. H. Trembley, J. M. Lahti, and V. J. Kidd. 2003. CDK11 complexes promote pre-mRNA splicing. J. Biol. Chem. 278:8623-8629.
13. International Human Genome Sequencing Consortium. 2004. Finishing the euchromatic sequence of the human genome. Nature 431:931-945.
14. International Human Genome Sequencing Consortium. 2001. Initial sequencing and analysis of the human genome. Nature 409:860-921.
15. Johnson, J. M., J. Castle, P. Garrett-Engele, Z. Kan, P. M. Loerch, C. D. Armour, R. Santos, E. E. Schadt, R. Stoughton, and D. D. Shoemaker. 2003. Genome-wide survey of human alternative pre-mRNA splicing with exon junction microarrays. Science 302:2141-2144.
16. Ko, T. K., E. Kelly, and J. Pines. 2001. CrkRS: a novel conserved Cdc2-related protein kinase that colocalises with SC35 speckles. J. Cell Sci. 114:2591-2603.
17. Li, X., and J. L. Manley. 2005. Inactivation of the SR protein splicing factor ASF/SF2 results in genomic instability. Cell 122:365-378.
18. Lin, S. D., and M. J. Fann. 1998. Differential expression of protein kinases in cultured primary neurons derived from the cerebral cortex, hippocampus, and sympathetic ganglia. J. Biomed. Sci. 5:111-119.
19. Lover, P., J. H. Trembley, R. Katona, V. J. Kidd, and J. M. Lahti. 2005. Role of CDK/cyclin complexes in transcription and RNA splicing. Cell Signal. 17:1033-1051.
20. Loyer, P., J. H. Trembley, J. M. Lahti, and V. J. Kidd. 1998. The RNP protein, RNPS1, associates with specific isoforms of the p34cdc2-related PITSLRE protein kinase in vivo. J. Cell Sci. 111:1495-1506.
21. Maniatis, T., and B. Tasic. 2002. Alternative pre-mRNA splicing and proteome expansion in metazoans. Nature 418:235-243.
22. Marques, F., J. L. Moreau, G. Peaucellier, J. C. Lozano, P. Schatt, A. Picard, I. Callebaut, E. Perret, and A. M. Geneviere. 2000. A new subfamily of high molecular mass CDC2-related kinases with PITAI/VRE motifs. Biochem. Biophys. Res. Commun. 279:832-837.
23. Murray, A. W., and D. Marks. 2001. Can sequencing shed light on cell cycling? Nature 409:844-846.
24. Nayler, O., W. Stratling, J. P. Bourquin, I. Stagljar, L. Lindemann, H. Jasper, A. M. Hartmann, F. O. Fackelmayer, A. Ullrich, and S. Stamm. 1998. SAF-B protein couples transcription and pre-mRNA splicing to SAR/MAR elements. Nucleic Acids Res. 26:3542-3549.
25. Philips, A. V., and T. A. Cooper. 2000. RNA processing and human disease. Cell. Mol. Life Sci. 57:235-249.
26. Screaton, G. R., J. F. Caceres, A. Mayeda, M. V. Bell, M. Plebanski, D. G. Jackson, J. I. Bell, and A. R. Krainer. 1995. Identification and characterization of three members of the human SR family of pre-mRNA splicing factors. EMBO J. 14:4336-4349.
27. Shin, C., and J. L. Manley. 2004. Cell signalling and the control of pre-mRNA splicing. Nat. Rev. Mol. Cell. Biol. 5:727-738.
28. van der Houven van Oordt, W., K. Newton, G. R. Screaton, and J. F. Caceres. 2000. Role of SR protein modular domains in alternative splicing specificity in vivo. Nucleic Acids Res. 28:4822-4831.
29. Venables, J. P. 2004. Aberrant and alternative splicing in cancer. Cancer Res. 64:7647-7654.
30. Wang, J., and J. L. Manley. 1995. Overexpression of the SR proteins ASF/SF2 and SC35 influences alternative splicing in vivo in diverse ways. RNA 1:335-346.
31. Yang, L., N. Li, C. Wang, Y. Yu, L. Yuan, M. Zhang, and X. Cao. 2004. Cyclin L2, a novel RNA polymerase II-associated cyclin, is involved in pre-mRNA splicing and induces apoptosis of human hepatocellular carcinoma cells. J. Biol. Chem. 279:11639-11648.
32. Yu, J. Y., S. L. DeRuiter, and D. L. Turner. 2002. RNA interference by expression of short-interfering RNAs and hairpin RNAs in mammalian cells. Proc. Natl. Acad. Sci. USA 99:6047-6052.
33. Zhang, W. J., and J. Y. Wu. 1996. Functional properties of p54, a novel SR protein active in constitutive and alternative splicing. Mol. Cell. Biol. 16:5400-5408.